State Street Corp Synaptogenix, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Synaptogenix, Inc. stock. As of the latest transaction made, State Street Corp holds 20,100 shares of SNPX stock, worth $82,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,100
Previous 20,100
-0.0%
Holding current value
$82,410
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SNPX
# of Institutions
25Shares Held
955KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny401KShares$1.64 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$633,3310.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il83.5KShares$342,5300.0% of portfolio
-
Two Sigma Securities, LLC New York, NY83.4KShares$341,9760.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA68.5KShares$280,9400.0% of portfolio
About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $28M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...